arrow
B

Barton F. Haynes

Duke University School of Medicine
H指数:144
被引数:7.7万
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Humans and rhesus macaques share maturation pathways of HIV-1 envelope-reactive V3-glycan bnAb lineages

人类和恒河猴共享HIV-1包膜反应性V3-糖基bnAb谱系的成熟途径

2026-07-080
PRE
Enhanced B cell priming induces broadly neutralizing HIV-1 apex antibodies

增强B细胞初始刺激诱导广泛中和HIV-1顶点抗体

Nature
IF48.5
2026-06-300
PRE
Mechanistic and antigenic boundaries of Henipavirus and Parahenipavirus glycoproteins

亨尼帕病毒和副亨尼帕病毒糖蛋白的机制和抗原边界

2026-06-190
OAAI
Induction of broadly neutralizing HIV antibodies by a two-step mechanism informs vaccine design

通过两步机制诱导广谱中和HIV抗体为疫苗设计提供信息

Science
IF45.8
2026-05-070
PRE
Env-antibody coevolution identifies B cell priming as the principal bottleneck to HIV V2 apex broadly neutralizing antibody development

Env-antibody共进化识别B细胞初始为HIV V2顶点广谱中和抗体发展的主要瓶颈

2026-02-130
PRE
ALFQ adjuvanted HIV-1 envelope protein vaccination elicits durable functional antibody and cellular responses in nonhuman primates

ALFQ佐剂HIV-1包膜蛋白疫苗接种在非人灵长类动物中诱导了持久的抗体和细胞免疫应答。

2025-12-190
OAAI
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivity

来自人类HIV-1疫苗试验参与者的糖链反应性抗体显示出广泛的病原体交叉反应性

2025-11-010
PRE
Acquisition of quaternary trimer interaction as a key step in the lineage maturation of a broad and potent HIV-1 neutralizing antibody

四聚体三聚体相互作用的形成作为广谱强效HIV-1中和抗体谱系成熟过程中的关键步骤

2025-05-230
PRE
Engineering immunogens that select for specific mutations in HIV broadly neutralizing antibodies
2024-11-030
OAAI
Comparison of the immunogenicity of mRNA-encoded and protein HIV-1 Env-ferritin nanoparticle designs
2024-09-171
PRE
SARS-CoV-2 Omicron XBB lineage spike structures, conformations, antigenicity, and receptor recognition
2024-07-010
OAAI
Vaccine-mediated protection against Merbecovirus and Sarbecovirus challenge in mice
2023-10-016
OAAI
Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertions
2023-04-0115
OAAI
A Germline-Targeting Chimpanzee SIV Envelope Glycoprotein Elicits a New Class of V2-Apex Directed Cross-Neutralizing Antibodies
MBIO
IF4.7
2023-02-284
OAAI